Leukemia Research
Volume 26, Issue 3 , Pages 297-299 , March 2002

Commentary: what is an ‘NK-precursor cell line’?

  • Hans G. Drexler

      Affiliations

    • DSMZ — German Collection of Microorganisms and Cell Cultures, Department of Human and Animal Cell Cultures, Mascheroder Weg 1B, 38124 Braunschweig, Germany
    • Corresponding Author InformationCorresponding author. +49-531-2616-160; fax: +49-531-2616-150
    • ,
  • Yoshinobu Matsuo

      Affiliations

    • Fujisaki Cell Center, Hayashibara Biochemical Laboratories, Okayama, Japan

Received 17 May 2001 ,Accepted 17 May 2001.

References 

  1. Drexler HG, Matsuo Y, MacLeod RAF. Continuous hematopoietic cell lines as model systems for leukemia–lymphoma research. Leuk. Res. 2000;24:881–911
  2. Drexler HG, Matsuo Y. Guidelines for the characterization and publication of human malignant hematopoietic cell lines. Leukemia. 1999;13:835–842
  3. Drexler HG, Matsuo Y. Malignant hematopoietic cell lines: in vitro models for the study of multiple myeloma and plasma cell leukemia. Leuk. Res. 2000;24:681–703
  4. Pellat-Deceunynk C, Amiot M, Bataille R, van Riet I, van Camp B, Omede P, et al. Human myeloma cell lines as a tool for studying the biology of multiple myeloma: a reappraisal 18 years after. Blood. 1995;86:4001–4002
  5. Jernberg-Wiklund H, Nilsson K. Multiple myeloma cell lines. In:  Masters JRW,  Palsson BO editor. Cancer cell lines. Part 3: leukemias and lymphomas. Human cell culture. III:Dordrecht: Kluwer; 2000;p. 81–155
  6. Drexler HG, Dirks WG, MacLeod RAF. False human hematopoietic cell lines: cross-contaminations and misinterpretations. Leukemia. 1999;13:1601–1607
  7. Dirks WG, MacLeod RAF, Drexler HG. ECV304 (endothelial) is really T24 (bladder carcinoma): cell line cross-contamination at source. In Vitro Cell Dev. Biol. 1999;35:558–559
  8. MacLeod RAF, Dirks WG, Kaufmann M, Matsuo Y, Milch H, Drexler HG. Widespread intraspecies cross-contamination of human tumor cell lines arising at source. Int. J. Cancer. 1999;83:555–563
  9. Brown J, Reading SJ, Jones S, Fitchett CJ, Howl J, Martin A, et al. Critical evaluation of ECV304 as a human endothelial cell model defined by genetic analysis and functional responses: a comparison with the human bladder cancer derived epithelial cell line T24/83. Lab. Invest. 2000;80:37–45
  10. Tanabe H, Takada Y, Minegishi D, Kurematsu M, Masui T, Mizusawa H. Cell line individualization by STR multiplex system in the cell bank found cross-contamination between ECV304 and EJ-1/T24. Tissue Cult. Res. Commun. 1999;18:329–338
  11. Masters JRW. Human cancer cell lines: fact and fantasy. Nature Rev. Mol. Cell Biol. 2000;1:233–236
  12. Hashimoto S, Toba K, Tsuchiyama J, Abe T, Yano T, Momoi A, et al. CD56+, NKp46+ cell line (MZ93) expressing T-cell and myeloid antigens. Leuk. Res. 2002;26:289–295
  13. Drexler HG, Matsuo Y. Malignant hematopoietic cell lines: in vitro models for the study of natural killer cell leukemia–lymphoma cell lines. Leukemia. 2000;14:777–782
  14. In:  Drexler HG editors. The leukemia–lymphoma cell line factsbook. San Diego: Academic Press; 2000;
  15. Kagami Y, Nakamura S, Suzuki R, Iida S, Yatabe Y, Okada Y, et al. Establishment of an IL-2-dependent cell line derived from ‘nasal-type’ NK/T-cell lymphoma of CD2+, sCD3−, CD3ε+, CD56+ phenotype and associated with the Epstein–Barr virus. Br. J. Haematol. 1998;103:669–677
  16. Yagita M, Huang CL, Umehara H, Matsuo Y, Tabata R, Miyake M, et al. A novel natural killer cell line from a patient with aggressive natural killer cell leukemia carrying a p53 point mutation. Leukemia. 2000;14:922–930
  17. Gong JH, Maki G, Klingemann HG. Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells. Leukemia. 1994;8:652–658
  18. Robertson MJ, Cochran KJ, Cameron C, Le JM, Tantravahi R, Ritz J. Characterization of a cell line, NKL, derived from an aggressive human natural killer leukemia. Exp. Hematol. 1996;24:406–415
  19. Tsuchiyama J, Yoshino T, Mori M, Kondoh E, Oka T, Akagi T, et al. Characterization of a novel human natural killer-cell line (NK-YS) established from natural killer cell lymphoma/leukemia associated with Epstein–Barr virus infection. Blood. 1998;92:1374–1383
  20. Nagata H, Konno A, Kimura N, Zhang Y, Kimura M, Demachi A, et al. Characterization of novel natural killer (NK)-cell and γδ T-cell lines established from primary lesions of nasal T/NK-cell lymphomas associated with the Epstein–Barr virus. Blood. 2001;97:708–713
  21. Yodoi J, Teshigawara K, Nikaido T, Fukui K, Noma T, Honjo T, et al. TCGF (IL-2)-receptor inducing factor(s). I. Regulation of IL 2 receptor on a natural killer-like cell line (YT cells). J. Immunol. 1985;134:1623–1630
  22. Drexler HG, Dirks WG, MacLeod RAF, Quentmeier H, Steube KG, Uphoff CC, editors. DSMZ catalogue of human and animal cell lines. 8th ed. Braunschweig, Germany, 2001 (website: http:// www.dsmz.de).

PII: S0145-2126(01)00116-3

Leukemia Research
Volume 26, Issue 3 , Pages 297-299 , March 2002

Article Tools